Yogendra M Kanthi MD
Vascular Medicine
Chief, Vascular Thrombosis and Inflammation, Lasker Investigator, National Heart, Lung, and Blood Institute at the National Institutes of Health // Assistant Professor, adjunct University of Michigan https://kanthi.lab.medicine.umich.edu
Join to View Full Profile
National Heart, Lung, and Blood InstituteNational Institutes of HealthBethesda, MD 20892
Dr. Kanthi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- https://kanthi.lab.medicine.umich.edu
Education & Training
University of Michigan Health SystemFellowship, Vascular Medicine, 2012 - 2013- University of MichiganFellowship, Cardiovascular Disease, 2009 - 2013
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 2005 - 2009
Ohio State University College of MedicineClass of 2005
Certifications & Licensure
MI State Medical License 2011 - 2028
MD State Medical License 2022 - 2026
OH State Medical License 2005 - 2026
American Board of Internal Medicine Cardiovascular Disease
National Board of Physicians and Surgeons Cardiovascular Disease- National Board of Physicians and Surgeons Internal Medicine
Awards, Honors, & Recognition
- Director’s Award for Innovation National Heart, Lung, and Blood Institute
- Director’s Award for Collaboration National Heart, Lung, and Blood Institute
- NIH Director’s Award National Institute’s of Health, 2023
- Join now to see all
Clinical Trials
- Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19 Start of enrollment: 2020 May 31
Publications & Presentations
PubMed
- SARS-CoV-2 Immune Complex-Mediated Neutrophil Activation.Kiana C Allen, Seth Warner, Heather L Teague, Marcos J Ramos-Benitez, Rui Miao
Open Forum Infectious Diseases. 2025-04-01 - Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infection.Pei-Suen Tsou, Ramadan A Ali, Chenyang Lu, Gautam Sule, Carmelo Carmona-Rivera
JCI Insight. 2025-04-01 - cMPL-Based Purification and Depletion of Human Hematopoietic Stem Cells: Implications for Pretransplant Conditioning.Daisuke Araki, So Gun Hong, Nathaniel Seth Linde, Bryan Fisk, Neelam Redekar
Blood. 2025-02-26
Authored Content
- Research website10/1/2018
Press Mentions
Rogue Antibodies Make Cells “Sticky” to Trigger Blood Clots in COVID-19 PatientsFebruary 17th, 2022- Can Autoimmune Antibodies Explain Blood Clots in COVID-19?November 17th, 2020
- College Student's Death Linked to COVID-19: What Young People Should KnowNovember 11th, 2020
- Join now to see all
Research History
- Mechanisms of venous thrombosis and inflammation
Professional Memberships
- Member
- Fellow
- Society for Vascular MedicineFellow
- American Venous ForumMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
